Cellebrite DI Ltd. (CLBT) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CLBT Revenue Growth
Revenue Breakdown (FY 2024)
CLBT's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
CLBT Revenue Analysis (2019–2025)
As of May 8, 2026, Cellebrite DI Ltd. (CLBT) generated trailing twelve-month (TTM) revenue of $475.7 million, reflecting strong growth of +18.1% year-over-year. The most recent quarter (Q4 2025) recorded $128.8 million in revenue, up 2.2% sequentially.
Looking at the longer-term picture, CLBT's 5-year compound annual growth rate (CAGR) stands at +19.5%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $475.7 million in 2025, representing a new all-time high.
Revenue diversification analysis shows CLBT's business is primarily driven by Subscription Services (71%), Term-Licenses (21%), and Professional Services (8%). With over half of revenue concentrated in Subscription Services, the company maintains significant focus in this area while developing other growth vectors.
When compared to Technology sector peers including AXON (+34.0% YoY), VRNS (+15.2% YoY), and OSPN (+1.7% YoY), CLBT has underperformed the peer group in terms of revenue growth. Compare CLBT vs AXON →
CLBT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CLBTCurrent | $476M | +18.1% | +19.5% | 14.0% | |
 AXON | $2.8B | +34.0% | +32.5% | -2.2% | |
 VRNS | $624M | +15.2% | +16.3% | -23.5% | |
 OSPN | $243M | +1.7% | +2.4% | 20.6% | |
 NTCT | $823M | +4.9% | -1.6% | -44.7% | |
 IIIV | $213M | -5.9% | +7.3% | 1.9% |
CLBT Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $475.7M | +18.6% | $400.5M | 84.2% | $66.5M | 14.0% |
| 2024 | $401.2M | +23.4% | $338.6M | 84.4% | $56.9M | 14.2% |
| 2023 | $325.1M | +20.1% | $271.9M | 83.6% | $33.2M | 10.2% |
| 2022 | $270.7M | +9.9% | $219.9M | 81.3% | $1.0M | 0.4% |
| 2021 | $246.2M | +26.3% | $203.7M | 82.7% | $13.8M | 5.6% |
| 2020 | $194.9M | +13.4% | $157.0M | 80.6% | $9.2M | 4.7% |
| 2019 | $171.9M | - | $136.0M | 79.2% | $-1,520,000 | -0.9% |
See CLBT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CLBT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CLBT vs NVDA
Side-by-side business, growth, and profitability comparison vs NVIDIA Corporation.
Start ComparisonCLBT — Frequently Asked Questions
Quick answers to the most common questions about buying CLBT stock.
Is CLBT's revenue growth accelerating or slowing?
CLBT revenue is accelerating at +18.1% year-over-year, exceeding the 5-year CAGR of +19.5%. TTM revenue reached $476M. Growth momentum has increased versus prior periods.
What is CLBT's long-term revenue growth rate?
Cellebrite DI Ltd.'s 5-year revenue CAGR of +19.5% reflects the sustained expansion pattern. Current YoY growth of +18.1% is above this long-term average.
How is CLBT's revenue distributed by segment?
CLBT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.